SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, reported record second-quarter 2026 revenue of $13.9 million, a 39.4% increase from $10.0 million in the same period last year. The company's first-half revenue reached $25.0 million, up 65.6% from $15.1 million in the prior year, according to a press release issued by the company.
The revenue surge was driven by continued demand for the SSi Mantra surgical robotic system. During the quarter, installations rose 30.4% to 30 systems, bringing the total installed base to 224 systems across 12 countries. Cumulative surgeries performed on the platform reached 12,272, reflecting growing clinical adoption and trust in the technology (https://nnw.fm/zxrT1).
Gross profit for the second quarter increased 20.0% to $7.1 million, though gross margin declined to 50.9% from 59.1% in the year-earlier quarter. For the first half, gross profit improved 77.5% to $12.4 million, with gross margin expanding compared to the prior-year period. The company attributes the margin dynamics to ongoing investments in scaling operations and expanding its global footprint.
Looking ahead, regulatory milestones in the U.S. and Europe could serve as significant catalysts. SS Innovations is targeting FDA clearance for the SSi Mantra by the first quarter of 2027 and EU CE marking by the end of 2026. These approvals would open large, developed markets and potentially accelerate adoption.
The company's telesurgery achievements are also extending the clinical profile of the SSi Mantra, demonstrating its capabilities beyond traditional operating room settings. However, system installations remain the primary commercial growth driver, and the recent quarterly performance indicates strong momentum in that area.
Investors and industry observers will be watching closely as SS Innovations continues to expand its installed base and prepares for potential regulatory approvals. The company's ability to maintain growth while managing margins will be key to its long-term success.
